|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
8
|
|
pubmed:dateCreated |
2007-5-14
|
|
pubmed:abstractText |
Increased preoperative prostate-specific antigen (PSA) velocity (PSAV) has been associated with increased prostate cancer mortality and higher Gleason scores. The authors evaluated the relation between PSAV, biopsy Gleason score, and pathologic stage in men who were enrolled in a prostate cancer screening trial.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
0008-543X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
15
|
|
pubmed:volume |
109
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1689-95
|
|
pubmed:dateRevised |
2007-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:17330856-Aged,
pubmed-meshheading:17330856-Clinical Trials as Topic,
pubmed-meshheading:17330856-Humans,
pubmed-meshheading:17330856-Male,
pubmed-meshheading:17330856-Middle Aged,
pubmed-meshheading:17330856-Neoplasm Staging,
pubmed-meshheading:17330856-Prognosis,
pubmed-meshheading:17330856-Prostate-Specific Antigen,
pubmed-meshheading:17330856-Prostatic Neoplasms,
pubmed-meshheading:17330856-ROC Curve,
pubmed-meshheading:17330856-Tumor Markers, Biological
|
|
pubmed:year |
2007
|
|
pubmed:articleTitle |
Prostate-specific antigen velocity and prostate cancer gleason grade and stage.
|
|
pubmed:affiliation |
Division of Cancer Prevention, National Cancer Institute, Bethesda, Maryland 20892, USA. pp4f@nih.gov
|
|
pubmed:publicationType |
Journal Article,
Research Support, N.I.H., Extramural
|
